Pharma Export
- All
- News
- Videos
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
Maiden Pharma Founder, Another Official Jailed In Decade-Old Case: Report
Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
Indian Pharma Exporters In Wait And Watch Mode as Russia Invades Ukraine
Indian pharma exporters are in wait and watch mode on dispatching fresh orders to them and some of the Commonwealth of Independent States' countries.
-
India Will Start Commercial Vaccine Exports With Shipments to Morocco, Brazil
Serum Institute of India will also send the Covid-19 vaccine to South Africa and Saudi Arabia
-
India's Auto, Pharma Sectors Not Ready To Wean Off China
India relies on China for products such as electronic components and drug ingredients because it cannot make them or source them elsewhere as cheaply, company and industry figures say.
-
Sensex Jumps Over 2,000 Points As Pharma, Financial Stocks Lead Gains
The pharma index soared by 10.2 per cent after the government lifted export restrictions on 24 drugs, which were imposed last month.
-
Government Eases Export Curbs On 24 Pharma Ingredients, Medicines
The government on Monday relaxed export curbs on 24 pharma ingredients and medicines, including vitamin B1 and B12, according to an official notification.
-
India's Curb On Pharma Export Raises Concern On Coronavirus Drugs Shortage
US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.
-
Government Puts Export Curbs On Pharma Ingredients Including Paracetamol Amid Virus Scare
The government on Tuesday put export restrictions on 26 pharma ingredients and medicines, including paracetamol, vitamin B1 and B12, amid the coronavirus outbreak in China, according to a government notification on Tuesday.
-
Government Restricts Export Of Some Pharma Ingredients, Drugs
Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.
-
Sensex, Nifty Edge Lower, But Register Weekly Gain: 10 Points
The Nifty IT declined 0.4 per cent, taking a breather after two days of gains led by weakness in the rupee. A fall in the rupee against the US dollar boosts profitability of exporters such as IT and pharma companies.
-
China To Provide "Greater Access" To Indian Anti-Cancer Drugs After Movie
China on Monday said it has initiated specific measures for the import of Indian pharmaceuticals, specially anti-cancer medicines, to provide them "greater access" to the Chinese market, days after a Chinese movie on a leukaemia patient highlighted the need for paving the way for import of cheap Indian medicines.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
Maiden Pharma Founder, Another Official Jailed In Decade-Old Case: Report
Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
Indian Pharma Exporters In Wait And Watch Mode as Russia Invades Ukraine
Indian pharma exporters are in wait and watch mode on dispatching fresh orders to them and some of the Commonwealth of Independent States' countries.
-
India Will Start Commercial Vaccine Exports With Shipments to Morocco, Brazil
Serum Institute of India will also send the Covid-19 vaccine to South Africa and Saudi Arabia
-
India's Auto, Pharma Sectors Not Ready To Wean Off China
India relies on China for products such as electronic components and drug ingredients because it cannot make them or source them elsewhere as cheaply, company and industry figures say.
-
Sensex Jumps Over 2,000 Points As Pharma, Financial Stocks Lead Gains
The pharma index soared by 10.2 per cent after the government lifted export restrictions on 24 drugs, which were imposed last month.
-
Government Eases Export Curbs On 24 Pharma Ingredients, Medicines
The government on Monday relaxed export curbs on 24 pharma ingredients and medicines, including vitamin B1 and B12, according to an official notification.
-
India's Curb On Pharma Export Raises Concern On Coronavirus Drugs Shortage
US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.
-
Government Puts Export Curbs On Pharma Ingredients Including Paracetamol Amid Virus Scare
The government on Tuesday put export restrictions on 26 pharma ingredients and medicines, including paracetamol, vitamin B1 and B12, amid the coronavirus outbreak in China, according to a government notification on Tuesday.
-
Government Restricts Export Of Some Pharma Ingredients, Drugs
Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.
-
Sensex, Nifty Edge Lower, But Register Weekly Gain: 10 Points
The Nifty IT declined 0.4 per cent, taking a breather after two days of gains led by weakness in the rupee. A fall in the rupee against the US dollar boosts profitability of exporters such as IT and pharma companies.
-
China To Provide "Greater Access" To Indian Anti-Cancer Drugs After Movie
China on Monday said it has initiated specific measures for the import of Indian pharmaceuticals, specially anti-cancer medicines, to provide them "greater access" to the Chinese market, days after a Chinese movie on a leukaemia patient highlighted the need for paving the way for import of cheap Indian medicines.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
